PensionDanmark Pensionsforsikringsaktieselskab Has $8.01 Million Stock Holdings in Humana Inc. $HUM

PensionDanmark Pensionsforsikringsaktieselskab grew its holdings in shares of Humana Inc. (NYSE:HUM) by 10.4% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,163 shares of the insurance provider’s stock after buying an additional 1,900 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Humana were worth $8,009,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Fiduciary Alliance LLC lifted its position in shares of Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after acquiring an additional 49 shares during the period. Sanctuary Advisors LLC increased its stake in Humana by 1.6% in the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after purchasing an additional 52 shares in the last quarter. Horizon Investments LLC raised its holdings in shares of Humana by 2.5% during the fourth quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock valued at $573,000 after purchasing an additional 55 shares during the period. CoreCap Advisors LLC boosted its position in shares of Humana by 74.7% during the 2nd quarter. CoreCap Advisors LLC now owns 159 shares of the insurance provider’s stock worth $63,000 after purchasing an additional 68 shares in the last quarter. Finally, CENTRAL TRUST Co boosted its position in shares of Humana by 36.5% during the 4th quarter. CENTRAL TRUST Co now owns 273 shares of the insurance provider’s stock worth $70,000 after purchasing an additional 73 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the company. Truist Financial boosted their target price on Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Sanford C. Bernstein reissued an “outperform” rating and issued a $425.00 price objective on shares of Humana in a research note on Wednesday, June 3rd. Seaport Research Partners downgraded Humana to a “neutral” rating in a report on Wednesday, May 20th. Piper Sandler upgraded Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a report on Thursday, July 30th. Finally, Oppenheimer reissued an “outperform” rating and issued a $405.00 price target on shares of Humana in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Humana currently has a consensus rating of “Moderate Buy” and an average target price of $391.87.

Humana Trading Up 4.7%

HUM opened at $384.44 on Friday. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The firm has a market capitalization of $46.16 billion, a PE ratio of 36.37, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The company’s 50-day moving average is $377.18 and its 200 day moving average is $271.65.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company’s quarterly revenue was up 26.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.27 EPS. As a group, research analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.